CD8-positive mantle cell lymphoma: A report of two cases

American Journal of Clinical Pathology

Volumn 109, Issue 6, 1998, Pages 689-694

  Hoffmann, Douglas G ^a   Tucker, Steven J ^a   Emmanoulides, Christos ^a   Rosen, Peter A ^a   Naeim, Faramarz ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blastic variant; CD8; Central nervous system; Flow cytometry; Leukemia; Mantle cell lymphoma

Indexed keywords

CD8 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN DERIVATIVE; ETOPOSIDE; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; VINCRISTINE SULFATE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DRUG RESISTANCE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MALE; MANTLE CELL LYMPHOMA; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031860271     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/109.6.689     Document Type: Article

References (19)

1. Teodorovic I, Pittaluga S, Kluin-Nelemans JC, et al. Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. J Clin Oncol. 1995;13:2819-2826.
2. Weisenberger DD, Armitage JO. Mantle cell lymphoma: an entity comes of age. Blood. 1996;87:4483-4494.
3. Wasman J, Rosenthal NS, Farhi DC. Mantle cell lymphoma: morphologic findings in bone marrow involvement. Am J Clin Pathol. 1996;106:196-200.
4. Kilo MN, Dorfman DM. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. Am J Clin Pathol. 1996;105:451-457.
5. Segal GH, Masih AS, Fox AC, et al. CD5-expressing B-cell non-Hodgkins lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood. 1995;85:1570-1579.
6. Fisher RI, Dahlberg S, Nathwani BN, et al. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood. 1995;85:1075-1082.
7. Vidriales MB, Orfao A, Gonzalez M, et al. Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemia. Leukemia. 1993;7:2026-2029.
8. Pui C, Raimondi SC, Head DR, et al. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood. 1990;78: 1327-1337.
9. Koelliker DD, Steele PE, Hurtubise PE, et al. CD8-positive B-cell chronic lymphocytic leukemia: a report of two cases. Am J Clin Pathol. 1994;102:212-216.
10. + B cell chronic lymphocytic leukemia. Leukemia. 1996;10:1544-1550.
11. Montserrat E, Bosch F, Lopez-Guillermo A, et al. CNS involvement in mantle-cell lymphoma. J Clin Oncol. 1996;14:941-944.
12. O'Rourke AM, Mescher MF. The roles of CD8 in cytotoxic T lymphocyte function. Immunol Today. 1993;14:183-188.
13. Rohrer JW, Coggin JH. CD8 T cell clones inhibit antitumor T cell function by secreting IL-10. J Immunol. 1995;155:5719-5727.
14. Greiner TC, Moynihan MJ, Chan WC, et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood. 1996;87:4302-4310.
15. Zoldan MC, Inghirami G, Masuda Y, et al. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome. Br J Hematol. 1996;93:475-486.
16. Haidar JH, Neiman RS, Orzi A, et al. mdm-2 oncoprotein expression in mantle cell lymphoma with blastoid transformation. Mod Pathol. 1996;9:355-359.
17. lck. Curr Top Microbiol Immunol. 1996;205:63-87.
18. lck kinase expression and control of DNA synthesis in activated human B lymphocytes. J Biol Chem. 1993;268:9169-9171.
19. Jucker M, Abts H, Eick D, et al. Overexpression of lck in Burkitt's lymphoma cell lines. Leukemia. 1991;5:528-530.